1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Venous study in TR-3D-CE-MRA for patients with pathology
Veinsa Interobserver Agreement (κ) Mean Visibility Score (/2) Sensitivity for Detection (%) SSS 1.00 2 100.0 TS 1.00 2 100.0 SR 1.00 2 100.0 Great cerebral 1.00 2 100.0 ISS 0.85 1.14 90.9 Internal cerebral 0.30 0.77 100.0 Basal 0.12 1.41 95.4
a Veins are listed in decreasing order of reproducibility: interobserver agreement, mean visibility score, and sensitivity of TR-3D-CE-MRA for detection.